Engineering the CD4+ T-Cell Response for Improved Immunity

Samuel Landry of Tulane University will research the use of immune tolerance of dominant HIV epitopes prior to conventional vaccination with an HIV protein in order to stimulate a broader immune response.

More information about Create New Ways of Protecting Against Infectious Diseases (Round 1)

Engineering the CD4+ T-Cell Response for Improved Immunity

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.